JACC: CardioOncology June 01, 2020 | Vol. 2 No. 2 – Table of Contents of this issue
ARTICLES IN THIS ISSUE (open access):
- ORIGINAL RESEARCH: Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy – ,
- EDITORIAL COMMENT: At the Heart of Safe and Successful Pregnancies in Cancer Survivors –
- Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
- EDITORIAL COMMENT: Examining Cardiotoxicity With HER2 Therapies – Neelima Denduluri
- Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
- EDITORIAL COMMENT: Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer – Erica L. Mayer
- Cardiovascular Effects of CAR T Cell TherapyA Retrospective Study – ,
- EDITORIAL COMMENT: Cytokines Are at the Heart of it – Cytokine Release Syndrome Underlies Cardiovascular Effects of CAR T Cell – Anna B. Catino
- Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity – Attila Feher, Albert J. Sinusas, et al.
- Anthracycline Cardiotoxicity – Can CT Move Us Further? Umberto Campia and
- Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis –
- EDITORIAL COMMENT: Can LV Strain Play a Role? – ,
- The TICONC (Ticagrelor-Oncology) StudyImplications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis ,
- Ticagrelor in Patients With Cancer2 Birds With 1 Stone
- STATE-OF-THE-ART REVIEW: COVID-19 Clinical TrialsA Primer for the Cardiovascular and Cardio-Oncology Communities Bonnie Ky and
- STATE-OF-THE-ART REVIEW: Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer TherapyJACC CardioOncology ,
- STATE-OF-THE-ART REVIEW: Cardiac Tumors – JACC CardioOncology –
- RESEARCH LETTER: Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer ,
- CLINICAL CASE CHALLENGES: Acute Heart Failure 29 Years After Treatment for Childhood Cancer – ,
- CLINICAL CASE CHALLENGES: Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease – ,
- CLINICAL CASE CHALLENGES: Cardiac Tamponade as the First Manifestation of Erdheim-Chester Disease – ,
- CLINICAL CASE CHALLENGES: Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants – ,
- INTERNATIONAL PERSPECTIVES: The Establishment of the Nordic Cardio-Oncology Society – ,
- INTERNATIONAL PERSPECTIVES: Cardio-Oncology in ArgentinaPast, Present, and Future – Andrés J. Daniele and
- LEADERSHIP PAGE: Cardio-Oncology in BrazilThe Dimensions of a New Era in the Care of Patients – Ludhmila Abrahão Hajjar and
- EDITOR’S PAGE: Resiliency and Our Cardio-Oncology Community – Bonnie Ky
- VIEWPOINT: Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors During the COVID-19 Pandemic – ,
- VIEWPOINT: The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer – ,
- VIEWPOINT: Cardio-Oncology Care in the Time of COVID-19 and the Role of Telehealth – ,
- VIEWPOINT: Impact of Cardiopulmonary Resuscitation on Survival in Cancer Patients Do Not Resuscitate Before or After CPR? – ,
CATEGORY
Cardio-Oncology in generalYEAR OF PUBLICATION 2020Cardiac arrhythmias and cancerCancer survivorsAnti-HER2 cardiotoxicityAnthracycline cardiotoxicityFluoropyrimidine cardiotoxicityCardiotoxicity of anticancer treatmentsCardiotoxicity and left ventricular dysfunctionCardiotoxicity and hypertensionCaso clinicoFOCUS ON: ESC & JACCGeneralVTE THROMBOEMBOLISM AND CANCER
Cardio-Oncology in generalYEAR OF PUBLICATION 2020Cardiac arrhythmias and cancerCancer survivorsAnti-HER2 cardiotoxicityAnthracycline cardiotoxicityFluoropyrimidine cardiotoxicityCardiotoxicity of anticancer treatmentsCardiotoxicity and left ventricular dysfunctionCardiotoxicity and hypertensionCaso clinicoFOCUS ON: ESC & JACCGeneralVTE THROMBOEMBOLISM AND CANCER